Nystatin, Neomycin Sulfate, Thiostrpton & Traimcinolone
99 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
99
Total Reports
16
Deaths Reported
1620.0%
Death Rate
Active Ingredients
Nystatin, Neomycin Sulfate, Thiostrpton & Traimcinolone
Administration Routes
TopicalUnknownAuricular (Otic)Parenteral
Species Affected
Dog 75
Cat 24
Most Affected Breeds
Domestic Shorthair 16
Chihuahua 8
Retriever - Labrador 6
Shih Tzu 5
Domestic Longhair 4
Bulldog - French 4
Terrier - Yorkshire 3
Mixed (Dog) 3
Shepherd Dog - German 3
Retriever - Golden 3
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 30
Vomiting 26
Anorexia 18
Diarrhoea 9
Death by euthanasia 8
Death 7
Other abnormal test result NOS 7
Decreased appetite 6
Elevated alanine aminotransferase (ALT) 6
Elevated liver enzymes 6
Seizure NOS 6
Hives (see also 'Skin') 6
Outcome Breakdown
Ongoing
65 (65.7%)
Recovered/Normal
11 (11.1%)
Died
9 (9.1%)
Outcome Unknown
7 (7.1%)
Euthanized
7 (7.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.